Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lyumjev (insulin lispro-aabc) for the Treatment of Type 1 and Type 2 Diabetes

Drug Name

Lyumjev™ (insulin lispro – aabc)

Developer

Eli Lilly and Company

Therapy Class

Fast acting human insulin

Product Description

Intravenous infusion or subcutaneous injection

Current Indication

Type 1 and type 2 diabetes

Market Sector

Diabetes

Development Status

Approved in the US, Europe and Japan
Expand
Close
Close
Close

Go Top